Citations for
1CD83, MARCHF8
Ubiquitin ligase MARCH 8 cooperates with CD83 to control surface MHC II expression in thymic epithelium and CD4 T cell selection
Liu H, Jain R, Guan J, Vuong V, Ishido S, La Gruta NL, Gray DH, Villadangos JA, Mintern JD.
J Exp Med. Aug 22;213(9):1695-703. doi: 10.1084/jem.20160312. Epub 2016 Aug 8. 2016
2CD83
CD83-stimulated monocytes suppress T-cell immune responses through production of prostaglandin E2.
Chen L, Zhu Y, Zhang G, Gao C, Zhong W, Zhang X.
Proc Natl Acad Sci U S A 108(46):18778-83. Epub 2011 Nov 7. 2011
3CD83
Activated T cells induce rapid CD83 expression on B cells by engagement of CD40.
Kretschmer B, Kühl S, Fleischer B, Breloer M.
Immunol Lett 136(2):221-7. Epub 2011 Jan 28. 2011
4CD83
Structural identification of recombinant human CD83 mutant variant as a potent therapeutic protein.
Zhang L, Narayanan N, Brand SR, Nicolette CA, Baroja M, Arp J, Wang H, Moo-Young M, Chou CP.
Protein Expr Purif 73(2):140-6. Epub 2010 Jun 8. 2010
5ANP32B, CD83
Phosphorylation of the HuR ligand APRIL by casein kinase 2 regulates CD83 expression.
Chemnitz J, Pieper D, Grüttner C, Hauber J.
Eur J Immunol 39(1):267-79. 2009
6CD83, RNF128
The transmembrane E3 ligase GRAIL ubiquitinates and degrades CD83 on CD4 T cells.
Su LL, Iwai H, Lin JT, Fathman CG.
J Immunol 183(1):438-44. 2009
7CD83
Engagement of CD83 on B cells modulates B cell function in vivo.
Kretschmer B, Lüthje K, Schneider S, Fleischer B, Breloer M.
J Immunol 182(5):2827-34. 2009
8CD83
Release and clinical significance of soluble CD83 in chronic lymphocytic leukemia.
Hock BD, Fernyhough LJ, Gough SM, Steinkasserer A, Cox AG, McKenzie JL.
Leuk Res 33(8):1089-95. Epub 2009 Feb 4. 2009
9CD83
CD83 expression in CD4+ T cells modulates inflammation and autoimmunity.
Reinwald S, Wiethe C, Westendorf AM, Breloer M, Probst-Kepper M, Fleischer B, Steinkasserer A, Buer J, Hansen W.
J Immunol 180(9):5890-7. 2008
10CD83
CD83 gene polymorphisms increase susceptibility to human invasive cervical cancer.
Zhang Z, Borecki I, Nguyen L, Ma D, Smith K, Huettner PC, Mutch DG, Herzog TJ, Gibb RK, Powell MA, Grigsby PW, Massad LS, Hernandez E, Judson PL, Swisher EM, Crowder S, Li J, Gerhard DS, Rader JS.
Cancer Res 67(23):11202-8. 2007
11CD83
CD83 modulates B cell function in vitro: increased IL-10 and reduced Ig secretion by CD83Tg B cells.
Kretschmer B, Lüthje K, Guse AH, Ehrlich S, Koch-Nolte F, Haag F, Fleischer B, Breloer M.
PLoS One 2(8):e755. 2007
12CD83
CD83 expression on dendritic cells and T cells: correlation with effective immune responses.
Aerts-Toegaert C, Heirman C, Tuyaerts S, Corthals J, Aerts JL, Bonehill A, Thielemans K, Breckpot K.
Eur J Immunol 37(3):686-95. 2007
13CD83
Prognostic significance of CD83 positive, mature dendritic cells in the gallbladder carcinoma.
Furihata M, Ono Y, Ichikawa K, Tomita S, Fujimori T, Kubota K.
Oncol Rep 14(2):353-6. 2005
14CD83
Alternative splicing generates putative soluble CD83 proteins that inhibit T cell proliferation.
Dudziak D, Nimmerjahn F, Bornkamm GW, Laux G.
J Immunol 174(11):6672-6. 2005
15CD83
CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells.
Cao W, Lee SH, Lu J.
Biochem J 385(Pt 1):85-93. 2005
16CD83
CD83 Expression Influences CD4(+) T Cell Development in the Thymus.
Fujimoto Y, Tu L, Miller AS, Bock C, Fujimoto M, Doyle C, Steeber DA, Tedder TF.
Cell 108(6):755-67. 2002
17CD83
the human dendritic cell marker CD83 maps to chromosome 6p23.
Berchtold S, Jones T, MŸhlzŸrbes P, Sheer D, Schuler G, Steinkasserer A.
Ann Hum Genet 63 : 181-183. 1999
18CAPZB, CD83, EDN1, GCNT2, HIVEP1, TFAP2A
Fine mapping of 39 ESTs on human chromosome 6p23-p25.
Olavesen MG, Bentley E, Mason RV, Stephens RJ, Ragoussis J.
Genomics 46(2):303-6. 1997